Companies that sell foreskin cells: Difference between revisions
m wikify Informed consent |
Cell Applications |
||
| Line 1: | Line 1: | ||
These companies offer foreskin cells online. This list is only a random sample taken from a search engine. More companies can be found searching for "human fibroblast neonate" or "human neonate keratinocytes". | These companies offer foreskin cells online. This list is only a random sample taken from a search engine. More companies can be found searching for "human fibroblast neonate" or "human neonate keratinocytes". | ||
== | == ATCC == | ||
ATCC is a private, nonprofit biological resource center (BRC) and research organization whose mission focuses on the acquisition, authentication, production, preservation, development and distribution of standard reference microorganisms, cell lines and other materials for research in the life sciences. | |||
ATCC was established in 1925 when a committee of scientists recognized a need for a central collection of microorganisms that would serve scientists all over the world. ATCC activities are housed in a Manassas, Virginia facility, since 1998. | |||
ATCC maintains nearly 4,000 cell lines for public health research, including lines used for the study of cancer, such as HeLa cells, as well as over 70,000 microbial cultures. The items on their repository have been used for the discovery, invention, and development of new, improved and emerging advances in the biological sciences arena.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url=http://www. | |url=http://www.atcc.org/en/About/About_ATCC/Ethical_Standards_for_Obtaining_Human_Materials.aspx | ||
|title= | |title=ATCC Ethical standards for obtaining human materials | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 14: | Line 18: | ||
}}</ref> | }}</ref> | ||
ATCC offers BJ (ATCC® CRL-2522™), fibroblasts from human neonate foreskin. The cells may be used for stable transfection studies.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url=http://www. | |url=http://www.atcc.org/Products/All/CRL-2522.aspx | ||
|title= | |title=BJ (ATCC CRL-2522) | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 34: | Line 29: | ||
}}</ref> | }}</ref> | ||
== Cell Applications == | |||
From an advertisement video: | |||
{{Citation | |||
|Text=At Cell Applications, Inc., primary Human Dermal Fibroblasts are isolated from the dermis of normal human neonatal [[foreskin]] or adult [[skin]]*. They are cryopreserved at the end of primary culture and can be cultured and propagated for at least 16 population doublings. The cells are tested positive for fibroblast surface protein, and can be shipped frozen or proliferating, with all the media reagents included. HDF provide a well-established system for in vitro analysis of fibroblast growth, migration and collagen metabolism. Fibroblasts grown in a biodegradable mesh have been used as a living dermal replacement. | |||
|Author=Cell Applications, Inc. | |||
}} | |||
<br> | |||
: <youtube>V4tmi_Ah1uI</youtube> | |||
== Life Technologies == | |||
Life Technologies, a Thermo Fisher Scientific Brand, offers Human Dermal Fibroblasts, neonatal (HDFn) part number C-004-5C, described as primary human dermal fibroblasts isolated from neonatal foreskin, cryopreserved at the end of the primary culture, for research use only. Cryopreserved HDFn are intended for use by researchers investigating the molecular and biochemical bases of | |||
various normal and disease processes. Not for use in diagnostic procedures.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url= | |url=https://www.lifetechnologies.com/order/catalog/product/C0045C | ||
|title= | |title=Catalog, product C0045C | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 43: | Line 52: | ||
|date= | |date= | ||
|accessdate=2015-06-30 | |accessdate=2015-06-30 | ||
}}</ref> | }}</ref> <ref>{{REFweb | ||
|quote= | |quote= | ||
|url= | |url=https://tools.lifetechnologies.com/content/sfs/manuals/HDFn_man.pdf | ||
|title= | |title=Life Technologies HDFn manual | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 62: | Line 63: | ||
}}</ref> | }}</ref> | ||
Life Technologies, now a brand of Thermo Fisher Scientific, traces its roots back to 1962 with the creation of Grand Island Biological Company (GIBCO) in Grand Island, New York, making serum harvested from horses raised on their land. The original Life Technologies, Inc., a subsidiary of Dexter Corp., was founded in 1983 by the merger of Bethesda Research Laboratories, Inc. and GIBCO Corporation. In 2000, Life Technologies was bought out by Invitrogen. Eight years later, following Invitrogen Corporation’s acquisition of Applied Biosystems Inc., Invitrogen renamed itself, creating the new Life Technologies Corp. In 2014, Life Technologies became the fourth premier brand within Thermo Fisher, the world leader in serving science.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url= | |url=https://www.lifetechnologies.com/us/en/home/about-us/news-gallery/company-fact-sheet/company-history.html | ||
|title= | |title=Life Technologies, company history | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 73: | Line 74: | ||
}}</ref> | }}</ref> | ||
== | == Lonza Group == | ||
Lonza was founded in Switzerland in 1897. It expanded to the United States in 1969. Lonza started its biotechnological business in 1980.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url= | |url=http://www.lonza.com/about-lonza/company-profile.aspx | ||
|title= | |title=Lonza, company profile | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 85: | Line 85: | ||
|date= | |date= | ||
|accessdate=2015-06-30 | |accessdate=2015-06-30 | ||
}}</ref> <ref>{{REFweb | }}</ref> | ||
Lonza offers Human Dermal Fibroblasts (NHDF). Clonetics™ Human Dermal Fibroblasts are available from either adult [[skin]] (NHDF-Ad) or neonatal foreskin (NHDF-Neo). They are derived from the dermis of normal human neonatal foreskin or adult [[skin]]. They are cryopreserved at the end of primary culture. | |||
Applications: | |||
* ECM protein analysis | |||
* Wound healing | |||
* Collagen metabolism | |||
* Cosmetics | |||
* Skin therapy/models | |||
All cells test negative for mycoplasma, bacteria, yeast, and fungi. [[HIV]]-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. A Certificate of Analysis is provided for each cell lot purchased.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url= | |url=http://www.lonza.com/products-services/bio-research/primary-cells/human-cells-and-media/fibroblasts-and-media/human-dermal-fibroblasts.aspx | ||
|title= | |title=Human dermal fibroblasts | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 96: | Line 107: | ||
}}</ref> | }}</ref> | ||
Clonetics™ Dermal Fibroblast Cell Systems contain Normal Human Dermal Fibroblasts (NHDF) and optimized media for their growth. Each System can quickly generate NHDF cultures for the study of disorders of human fibroblasts such as fibrosis, scleroderma, fibrosarcoma, xeroderma pigmentosum and histiocytoma.<ref>{{REFweb | |||
|quote= | |quote= | ||
|url= | |url=http://bio.lonza.com/uploads/tx_mwaxmarketingmaterial/Lonza_ManualsProductInstructions_TechSheet_-_Dermal_Fibroblast_Cell_Systems_NHDF.pdf | ||
|title= | |title=Lonza Dermal fibroblasts cell systems - techsheet | ||
|last= | |last= | ||
|first= | |first= | ||